Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.521NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.521NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.378NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.378NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.206NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.206NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.61NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.61NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.37NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.37NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XASNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XASNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.3.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.3.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CN.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CN.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.17NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BG.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BG.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.1.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.1.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.62NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.62NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.391NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.391NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.448NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.448NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Q.1 (Alpha)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Q.1 (Alpha)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.507NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.507NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.54NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.54NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.196NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.196NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.57NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.57NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used